A new survey found that most adults don't recognize common breast cancer symptoms, aside from a lump in the breast. Because lumps can take time to develop, experts stress the importance of knowing all the symptoms associated with breast cancer, to best recognize the disease in the earliest stages.
Dionisia Quiroga, DO, PhD, discusses the emergence of the HER2-low categorization in breast cancer as well as current treatment options for patients with HER2-low disease.
Bhuvaneswari Ramaswamy, MD, and colleagues highlight treatment for patients with HR-positive breast cancer, discuss the role of pembrolizumab plus chemotherapy in early-stage triple-negative breast cancer, and expand on unmet needs for patients with metastatic HER2-positive breast cancer.